AKT1 and cancer: KEGG enrichment analysis showed that the top five KEGG pathways with high counts included pathways in cancer, prolactin signalling pathway, EGFR tyrosine kinase inhibitor resistance, hepatitis B pathway, PI3K–Akt signalling pathway (Figures 6b).